Tylenol Precise Nighttime Pain Relieving Cream
NDC 69968-0905
Product Information
Tylenol Precise Nighttime Pain Relieving (camphor, menthol) is a OTC MONOGRAPH DRUG-approved product labeled by Kenvue Brands Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a cream for topical administration. This product entry covers the primary NDC 69968-0905 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 69968-0905?
What are the uses of this product?
What are Active Ingredients of this product?
- CAMPHOR (SYNTHETIC) 40 mg/g
- MENTHOL 12.5 mg/g - A monoterpene cyclohexanol produced from mint oils.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET)
- CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET) (Active Moiety)
- MENTHOL (UNII: L7T10EIP3A)
- MENTHOL (UNII: L7T10EIP3A) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CARBOMER INTERPOLYMER TYPE A (55000 CPS) (UNII: 59TL3WG5CO)
- WATER (UNII: 059QF0KO0R)
- GLYCERIN (UNII: PDC6A3C0OX)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- SORBITAN OLIVATE (UNII: MDL271E3GR)
- VANILLYL BUTYL ETHER (UNII: S2ULN37C9R)
- CETEARYL OLIVATE (UNII: 58B69Q84JO)
- CETYL ALCOHOL (UNII: 936JST6JCN)
- ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2604039 - camphor 4 % / menthol 1.25 % Topical Cream
- RxCUI: 2604039 - camphor 40 MG/ML / menthol 12.5 MG/ML Topical Cream
* Please review the full disclaimer at the bottom of this page.